Zobrazeno 1 - 10
of 226
pro vyhledávání: '"Peter Spiegler"'
Publikováno v:
Chest. 163:e13-e18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd05bc48160dc90649418922de6d08c7
https://doi.org/10.1016/j.chest.2022.04.140
https://doi.org/10.1016/j.chest.2022.04.140
Autor:
Mangalore Amith Shenoy, Peter Spiegler
Publikováno v:
Pathy's Principles and Practice of Geriatric Medicine. :555-560
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::656aa1c8fc29533a2f205db545f388d2
https://doi.org/10.1002/9781119484288.ch43
https://doi.org/10.1002/9781119484288.ch43
Autor:
Bonnie E. Lonze, Peter Spiegler, Russell N. Wesson, Nada Alachkar, Eva Petkova, Elaina P. Weldon, Rebecca A. Dieter, Yi Li, Max Quinn, Aprajita Mattoo, Irfana Soomro, Steven M. Cohen, Sherry Leung, Cecilia L. Deterville, B. Mark Landrum, Muhammad Imran Ali, David J. Cohen, Andrew L. Singer, Ayan Sen, Edward Chong, Judith S. Hochman, Andrea B. Troxel, Robert A. Montgomery
Publikováno v:
Critical care medicine. 50(9)
We designed this study to test whether clazakizumab, a direct interleukin-6 inhibitor, benefits patients hospitalized with severe or critical COVID-19 disease accompanied by hyperinflammation.Multicenter, randomized, double-blinded, placebo-controlle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac8492e12f570535c0d9f79ef4c243f3
https://pubmed.ncbi.nlm.nih.gov/35984056
https://pubmed.ncbi.nlm.nih.gov/35984056
Autor:
Wai Man Wang, Xian Jie Chen, Juri Chung, Wai Kin Li, Shahidul Islam, Diana Altshuler, Peter Spiegler, Shari Brosnahan
Publikováno v:
Critical Care Medicine. 51:551-551
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca2ded0fc8ef9ceae7d776f066668235
https://doi.org/10.1097/01.ccm.0000910168.10351.e4
https://doi.org/10.1097/01.ccm.0000910168.10351.e4
Autor:
Wai Kin, Li, Xian Jie Cindy, Chen, Diana, Altshuler, Shahidul, Islam, Peter, Spiegler, Liane, Emerson, Michael, Bender
Publikováno v:
Journal of Critical Care. 71:154098
PRIS is a potentially fatal syndrome characterized by various clinical symptoms and abnormalities. Experts suggest that propofol treatment duration ≥48 h or dose ≥83 μg/kg/min is associated with developing PRIS. We hypothesized PRIS might be und
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcbefe20ee1fda40ee196f797cdd98c8
https://doi.org/10.1016/j.jcrc.2022.154098
https://doi.org/10.1016/j.jcrc.2022.154098
Publikováno v:
The Annals of pharmacotherapy. 56(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a007e0a27b86089266a0f8ebfa1998b1
https://pubmed.ncbi.nlm.nih.gov/34330160
https://pubmed.ncbi.nlm.nih.gov/34330160
Autor:
Megan D. Winner, Diana Altshuler, Sam Parnia, Jasmin Divers, Sarun V. Thomas, Juri Chung, Shahidul Islam, Daniel H. Sterman, Xian Jie Cindy Chen, Peter Spiegler, Shari B. Brosnahan, Allison Greco
Publikováno v:
The Annals of Pharmacotherapy
Background Severe hypoxic respiratory failure from COVID-19 pneumonia carries a high mortality risk. There is uncertainty surrounding which patients benefit from corticosteroids in combination with tocilizumab and the dosage and timing of these agent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95e7b044a756ed0cfc4e5aec4f3f4461
https://pubmed.ncbi.nlm.nih.gov/34330173
https://pubmed.ncbi.nlm.nih.gov/34330173
Autor:
Wai Kin Li, Xian Jie Chen, Diana Altshuler, Shahidul Islam, Liane Emerson, Peter Spiegler, Michael Bender
Publikováno v:
Critical Care Medicine. 50:459-459
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3f9d7049bc179493dcd1c6dc0051e076
https://doi.org/10.1097/01.ccm.0000810024.58411.e3
https://doi.org/10.1097/01.ccm.0000810024.58411.e3
Autor:
Allison B. Reiss, Peter Spiegler, Amy D Glass, David Grossfeld, Heather A. Renna, Lora J. Kasselman, Joshua DeLeon, Priya Agarwala, Daniel S. Glass
Publikováno v:
Respiratory investigation. 58(5)
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease with high mortality that commonly occurs in middle-aged and older adults. IPF, characterized by a decline in lung function, often manifests as exertional dyspnea and cough. Symptom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acab6a1f76813d2cb654d5c9704c193d
https://pubmed.ncbi.nlm.nih.gov/32487481
https://pubmed.ncbi.nlm.nih.gov/32487481
Autor:
Peter Spiegler, Linda B. Haramati, Vincent Cascio, Douglas S. Katz, Animesh Gour, Sanjeev Bhalla, Man Hon
Obesity is a growing problem around the world, and radiology departments frequently encounter difficulties related to large patient size. Diagnosis and management of suspected venous thromboembolism, in particular deep venous thrombosis (DVT) and pul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4517edd8d987f244ea37655cd7bc05fc
https://europepmc.org/articles/PMC6223165/
https://europepmc.org/articles/PMC6223165/
